Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Ertapenem:Susc:Pt:Isolate:OrdQn:MIC

Known as: Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC), Ertapenem:Susc:Pt:Isolato:OrdQn:MIC, Ertapenem:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Minimum Inhibitory Concentration 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
ABSTRACT The minimal concentration of antibiotic required to inhibit the growth of different isolates of a given species with no… 
2013
2013
ABSTRACT Enterobacteriaceae producing the OXA-48 carbapenemase are emerging worldwide, leaving few treatment options. Efficacy… 
  • table 1
  • figure 1
  • figure 2
2012
2012
ABSTRACT A retrospective study was conducted at two medical centers in Taiwan to evaluate the clinical characteristics, outcomes… 
2011
2011
For 244 patients with bacteremia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae… 
  • table 1
  • table 2
  • table 3
  • table 4
2009
2009
Ertapenem, a Group 1 carbapenem, is most recently introduced into the market. It is a beta-lactam antibiotic that possesses a… 
2007
2007
ZusammenfassungGRUNDLAGEN: Infektionen sind die häufigsten Komplikationen nach Organtransplantationen. Bakterien gehören zu den h… 
2002
2002
This study compared the in vitro activities of ertapenem (Merck & Co., Inc.), ceftriaxone, amoxicillin-clavulanate, and…